Bridgeway Capital Management’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.5K Hold
95,434
﹤0.01% 1151
2025
Q1
$29.8K Sell
95,434
-133,681
-58% -$41.7K ﹤0.01% 1144
2024
Q4
$214K Sell
229,115
-80,425
-26% -$75.1K ﹤0.01% 993
2024
Q3
$365K Sell
309,540
-42,630
-12% -$50.3K 0.01% 931
2024
Q2
$271K Sell
352,170
-5,700
-2% -$4.38K 0.01% 988
2024
Q1
$1.09M Sell
357,870
-81,475
-19% -$248K 0.02% 729
2023
Q4
$1.41M Sell
439,345
-19,355
-4% -$62.3K 0.03% 681
2023
Q3
$1.76M Sell
458,700
-342,452
-43% -$1.32M 0.04% 582
2023
Q2
$2.63M Sell
801,152
-26,428
-3% -$86.7K 0.06% 468
2023
Q1
$2.14M Sell
827,580
-83,620
-9% -$216K 0.06% 505
2022
Q4
$1.69M Buy
911,200
+2,700
+0.3% +$5.02K 0.04% 602
2022
Q3
$1.67M Sell
908,500
-75,200
-8% -$138K 0.04% 582
2022
Q2
$2.12M Buy
983,700
+615,600
+167% +$1.32M 0.05% 522
2022
Q1
$1.16M Buy
368,100
+156,700
+74% +$492K 0.02% 743
2021
Q4
$679K Hold
211,400
0.01% 893
2021
Q3
$710K Hold
211,400
0.01% 932
2021
Q2
$827K Sell
211,400
-18,000
-8% -$70.4K 0.01% 921
2021
Q1
$922K Buy
+229,400
New +$922K 0.02% 890
2020
Q2
Sell
-242,600
Closed -$723K 1377
2020
Q1
$723K Hold
242,600
0.02% 651
2019
Q4
$1.01M Buy
242,600
+32,400
+15% +$134K 0.01% 737
2019
Q3
$681K Buy
210,200
+150,000
+249% +$486K 0.01% 841
2019
Q2
$111K Sell
60,200
-24,240
-29% -$44.7K ﹤0.01% 1241
2019
Q1
$149K Sell
84,440
-14,000
-14% -$24.7K ﹤0.01% 1252
2018
Q4
$238K Sell
98,440
-10,000
-9% -$24.2K ﹤0.01% 1187
2018
Q3
$615K Hold
108,440
0.01% 1089
2018
Q2
$846K Hold
108,440
0.01% 933
2018
Q1
$767K Buy
108,440
+59,440
+121% +$420K 0.01% 933
2017
Q4
$484K Buy
+49,000
New +$484K 0.01% 1099